Cargando…
Histopathological investigation of glioblastomas resected under bevacizumab treatment
To date, no clinical observations have been reported for histopathological changes in human gliomas under antiangiogenic treatment. We collected six glioblastomas resected under bevacizumab treatment. Histopathological investigation was performed by hematoxilyn-eosin staining and immunohistochemistr...
Autores principales: | Tamura, Ryota, Tanaka, Toshihide, Miyake, Keisuke, Tabei, Yusuke, Ohara, Kentaro, Sampetrean, Oltea, Kono, Maya, Mizutani, Katsuhiro, Yamamoto, Yohei, Murayama, Yuichi, Tamiya, Takashi, Yoshida, Kazunari, Sasaki, Hikaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239563/ https://www.ncbi.nlm.nih.gov/pubmed/27244880 http://dx.doi.org/10.18632/oncotarget.9387 |
Ejemplares similares
-
Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2018) -
“Paradoxical” findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab
por: Yamamoto, Yohei, et al.
Publicado: (2017) -
Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2020) -
ANGI-01 ALTERATION IN IMMUNE REGULATORY CELLS BEFORE AND AFTER TREATMENT BY STUPP REGIMEN WITH OR WITHOUT BEVACIZUMAB FOR GLIOBLASTOMA
por: Tanaka, Toshihide, et al.
Publicado: (2019) -
Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas
por: Takei, Jun, et al.
Publicado: (2022)